Dobreva, Miryana, Sanofi S.p.A., Milano, Italy, Italy

• Vol 23, No 1 (2022) - Original research
  [Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]
  Abstract  HTML  PDF